EP Biocomposites Limited Reports Strong FY26 Results

EP Biocomposites Limited (BSE: 543595), manufacturer of fibre reinforced composite products and waste water solutions, announced its audited financial results for the financial year ended March 31, 2026.

Key Highlights of H2 & FY26

- Net worth crossed X12 crore as on March 31, 2026, reflecting continued financial strengthening.

- ROI stood at 14%, while ROCE improved to 16% during FY26

- Successfully utilized IPO proceeds towards capacity expansion, working capital, and business growth initiatives.

- Strengthened balance sheet through partial debt repayment and improved liquidity position.

- Continued focus on operational excellence, infrastructure enhancement, and sustainable growth initiatives.

Commenting on the performance, Mr. Rajkumar Kamat, Managing Director of EP Biocomposites Limited, said: "FY26 has been a significant year for EP Biocomposites Limited as we delivered healthy growth in revenue and profitability while continuing to strengthen our balance sheet and operational capabilities. Our focus on sustainable manufacturing solutions, efficient execution, and customer relationships has enabled us to achieve consistent performance. We remain optimistic about future growth opportunities and are committed to creating long-term value for all stakeholders."

Shares of EP Biocomposites Limited was last trading in BSE at Rs. 109.00 as compared to the previous close of Rs. 108.70. The total number of shares traded during the day was 1500 in over 3 trades.

The stock hit an intraday high of Rs. 112.45 and intraday low of 101.00. The net turnover during the day was Rs. 161225.00.

Source : Equity Bulls

Keywords

EPBiocomposites INE0D2I01014 WasteManagement Q4FY26 Q4FY2026 FY26 FY2026 ResultUpdate